QR kód

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Abstract Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune system's T-cells to recognize and attack tumor cells. T-cells are isolated from patients and modified to target...

Celý popis

Uloženo v:
Hlavní autoři: Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Muzafar A. Macha, Mohammad Haris, Shahab Uddin, Mayank Singh, Ajaz A. Bhat
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2023-07-01
Edice:Journal of Translational Medicine
Témata:
CAR-T cell therapy
Immunotherapy
Tumor antigens
Antigen escape
Cytokine release syndrome
Hematological malignancy
On-line přístup:https://doi.org/10.1186/s12967-023-04292-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky